Gene · 406940
Papers4,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity. | J Exp Clin Cancer Res | 2023 | 37308974 | PubTator, text mining | PubMed |
| Sex and gender influence on immunity and autoimmunity. | Front Immunol | 2023 | 37304263 | PubTator, text mining | PubMed |
| Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches. | Front Mol Biosci | 2023 | 37304067 | PubTator, text mining | PubMed |
| LncRNA HOXA11-AS modulates the miR-148b-3p/MLPH axis to promote prostate cancer cell proliferation. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37300684 | PubTator, text mining | PubMed |
| The Mechanism of DNA Methylation and miRNA in Breast Cancer. | Int J Mol Sci | 2023 | 37298314 | PubTator, text mining | PubMed |
| miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy. | Int J Mol Sci | 2023 | 37298143 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives. | J Cardiovasc Transl Res | 2023 | 37286924 | PubTator, text mining | PubMed |
| Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p. | Front Pharmacol | 2023 | 37284323 | PubTator, text mining | PubMed |
| Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases. | Int J Nanomedicine | 2023 | 37283714 | PubTator, text mining | PubMed |
| The essential molecular requirements for the transformation of normal cells into established cancer cells, with implications for a novel anti-cancer agent. | Cancer Rep (Hoboken) | 2023 | 37279947 | PubTator, text mining | PubMed |
| Endogenous and viral microRNAs in nasal secretions of water buffaloes (Bubalus bubalis) after Bubaline alphaherpesvirus 1 (BuHV-1) challenge infection. | Vet Res | 2023 | 37277883 | PubTator, text mining | PubMed |
| Exosomes in metastasis of colorectal cancers: Friends or foes? | World J Gastrointest Oncol | 2023 | 37275444 | PubTator, text mining | PubMed |
| New molecular targets in Hodgkin and Reed-Sternberg cells. | Front Immunol | 2023 | 37266436 | PubTator, text mining | PubMed |
| Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives. | Pharmaceuticals (Basel) | 2023 | 37259418 | PubTator, text mining | PubMed |
| Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells. | Pharmaceuticals (Basel) | 2023 | 37259388 | PubTator, text mining | PubMed |
| Long-term outcomes and potential mechanisms of offspring exposed to intrauterine hyperglycemia. | Front Nutr | 2023 | 37255932 | PubTator, text mining | PubMed |
| Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis. | Front Immunol | 2023 | 37251412 | PubTator, text mining | PubMed |
| Emerging functions and clinical applications of exosomal microRNAs in diseases. | Noncoding RNA Res | 2023 | 37250456 | PubTator, text mining | PubMed |
| Differential expression profiles of plasma exosomal microRNAs in dilated cardiomyopathy with chronic heart failure. | J Cell Mol Med | 2023 | 37243441 | PubTator, text mining | PubMed |
| Multifunctional Milk-Derived Small Extracellular Vesicles and Their Biomedical Applications. | Pharmaceutics | 2023 | 37242660 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406940/papers?page=18